Literature DB >> 11979003

Complications of pancreatic cancer resection.

C M Halloran1, P Ghaneh, L Bosonnet, M N Hartley, R Sutton, J P Neoptolemos.   

Abstract

Pancreatic cancer is a common cause of cancer death in the developed world. Currently, resection is the only chance of long-term survival. The post-operative mortality in nonspecialist centres often exceeds 20% but is around 6% or less in specialist centres. The overall complication rate even in specialist centres is 18-54%. An analysis of eleven large series of pancreatic resections shows an incidence of common complications of 10.4% for fistula, 9.9% for delayed gastric emptying, 4.8% for bleeding, 4.8% for wound infection and 3.8% for intra-abdominal abscess. The median hospital stay is 13-18 days in different series. The re-operation rate varies from 4 to 9% with a mortality rate of 23 to 67%. Major complications are a significant factor in post-operative mortality, especially if they require re-operation. The use of octreotide or somatostatin to prevent complications is supported by several multicentre, double-blind, randomized controlled trials. The best way to improve outcome is to concentrate pancreatic cancer care in regional specialist centres. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11979003     DOI: 10.1159/000052029

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  47 in total

Review 1.  Pancreatic surgery: evolution and current tailored approach.

Authors:  Mario Zovak; Dubravka Mužina Mišić; Goran Glavčić
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

2.  [Diagnosis and treatment of chronic anastomotic fistulas].

Authors:  M Sailer; D Bussen; A Thiede
Journal:  Chirurg       Date:  2004-05       Impact factor: 0.955

3.  A modern approach to teaching pancreatic surgery: stepwise pancreatoduodenectomy for trainees.

Authors:  Gabriele Marangoni; Gareth Morris-Stiff; Sunita Deshmukh; Abdul Hakeem; Andrew M Smith
Journal:  J Gastrointest Surg       Date:  2012-06-20       Impact factor: 3.452

4.  Pancreaticojejunal bridge-anastomosis: a novel option for surgeon to preserve pancreatic body and tail in urgent reoperation for intra-abdominal massive hemorrhage after pancreaticoduodenectomy.

Authors:  Jin Xu; Xianwei Dai; Xianmin Bu; Feng Gao; Xiaobo Zhang
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

5.  Risk factors for 30-day hospital readmission among general surgery patients.

Authors:  Michael T Kassin; Rachel M Owen; Sebastian D Perez; Ira Leeds; James C Cox; Kurt Schnier; Vjollca Sadiraj; John F Sweeney
Journal:  J Am Coll Surg       Date:  2012-06-21       Impact factor: 6.113

6.  Treatment of bacteriobilia decreases wound infection rates after pancreaticoduodenectomy.

Authors:  Somala Mohammed; Charity Evans; George VanBuren; Sally E Hodges; Eric Silberfein; Avo Artinyan; Qianxing Mo; Medhi Issazadeh; Amy L McElhany; William E Fisher
Journal:  HPB (Oxford)       Date:  2013-08-29       Impact factor: 3.647

Review 7.  Trials of gene therapy for pancreatic carcinoma.

Authors:  Christopher M Halloran; Paula Ghaneh; Eithne Costello; John P Neoptolemos
Journal:  Curr Gastroenterol Rep       Date:  2005-06

8.  Early hospital readmission for gastrointestinal-related complications predicts long-term mortality after pancreatectomy.

Authors:  Caitlin W Hicks; Jeffrey J Tosoian; Rebecca Craig-Schapiro; Vicente Valero; John L Cameron; Frederic E Eckhauser; Kenzo Hirose; Martin A Makary; Timothy M Pawlik; Nita Ahuja; Matthew J Weiss; Christopher L Wolfgang
Journal:  Am J Surg       Date:  2015-06-29       Impact factor: 2.565

9.  Analysis of risk factors for hemorrhage and related outcome after pancreatoduodenectomy in an intermediate-volume center.

Authors:  Fabio Uggeri; Luca Nespoli; Marta Sandini; Anita Andreano; Luca Degrate; Fabrizio Romano; Laura Antolini; Luca Gianotti
Journal:  Updates Surg       Date:  2019-08-02

Review 10.  Pancreatic fistula after pancreatectomy: evolving definitions, preventive strategies and modern management.

Authors:  Shailesh-V Shrikhande; Melroy-A D'Souza
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.